ResearchAndMarkets.com added two related pharmaceutical-industry reports in Dublin: the Pharmaceutical Regulatory Affairs Market - Global Strategic Business Report on Sept. 30, 2026, and the Pharmacovigilance - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) report on Oct. 1, 2026. The regulatory affairs market is projected to expand from $9.2 billion in 2024 to $12.5 billion by 2030 at a 5.2% compound annual growth rate, driven by regulatory complexity, global drug development, biopharmaceutical innovation, digital systems and outsourcing. The pharmacovigilance market, which covers medicine-safety monitoring, was valued at USD 9.35 billion in 2025 and is forecast to increase from USD 10.45 billion in 2026 to USD 18.26 billion by 2031 at an 11.78% CAGR, supported by rising drug consumption, adverse-reaction reporting, advanced therapies, artificial intelligence and contract outsourcing. The reports also identify cybersecurity, privacy, regulatory fragmentation and shortages of specialized personnel as constraints.